Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-15

Clinical Trial Update: Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing desmopressin to placebo in adult female patients with nocturia shows superior reduction in night voids; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desmopressin (Desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia | Phase 3 | Status: COMPLETED | Results posted: 2015-10-15